Dr Katie Doores. “Development of a safe and effective HIV vaccine will have a huge impact on global health.” Dr Doores research encompasses the development of carbohydrate-based vaccines and therapeutics, and neutralising antibody responses against pathogenic viruses.

Looking for an enthusiastic and motivated research assistant/tech to work with me and Michael Malim to study the immune response to SARS-CoV-2. jobs.kcl.ac.uk/gb/en/job/0129…. #antibodies #COVID

Looking for a postdoc to join our exciting and fast paced research on antibody responses to SARS-CoV-2. jobs.kcl.ac.uk/gb/en/job/0162…. #antibody #COVID

#SARSCoV2_Spike #B117_variant | Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes | Katie Doores King's College London Immunity buff.ly/3rQBNgw

We are hiring! 3-year MRC funded postdoc position in the Doores Lab to study humoral immunity to hantaviruses. jobs.kcl.ac.uk/gb/en/job/0250…

PhD opportunity starting Sept 2021! Sensitising solid cancers to CAR T-cell therapy using matrix remodelling bacteria. You'll be working between Barts Cancer Institute (Queen Mary) and an exciting new biotech start-up. findaphd.com/phds/project/s…

OUT NOW: Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern #SARSCoV2 By Katie Doores & co DooresLab read it here: rdcu.be/czzqM nature.com/articles/s4156…

🎉Celebrations are in full swing for our #COVID19 Emerging Leaders Prize winners! 🏆Dr Katie Doores DooresLab 🏆Dr Rosalind Eggo Dr Roz Eggo 🏆Dr Antonia Ho Antonia Ho 🏆Dr Koen Pouwels Koen B Pouwels Huge thanks to our sponsor Pfizer UK and speakers Berkeley Phillips & @Daltmann10👏

PhD opportunity starting Sept 2023. Supervised by Peter Cherepanov (Crick) and myself (KCL). Study mechanisms of SARS-CoV-2 antibody cross-neutralization using X-ray crystallography and cryo-EM. crick.ac.uk/careers-study/…